Post by
Forestview on Jan 11, 2021 9:22am
Not a good sign
When both Marky and Mugsy are disappointed. :(
But, maybe 3B has a point. Nothing has changed with the science. What we got here were soe vague details and some delays (which are covid driven). If the FDA application happens in a matter of weeks, let's say end of Feb, and it's approved by early Q2 (is that possible?) then we should see a spike. In the end, the IP is sound. We all know that. Nothing's changed there.
I do wonder though if we will have see buy outs in the billions. I may need to temper my expectations and re work my retirement model to something more realistic. Dan doesn't seem to be aggressive from that perspective.
Stay long. I've been in this for two years, and doubled my position over the last six months. I'm not selling, I'm just going to be less optimistic.
Comment by
MrMugsy on Jan 11, 2021 9:30am
Well ... the partnering is still on track ... from what I can see. That's the wild card. Anything can happen here. We have some delay which shouldn't be a surprise but it isn't ideal for the product plan (OTENA). More questions than answers if you've been here a while ... that's all ... hahaha ...
Comment by
Straylight on Jan 11, 2021 10:04am
Price hitting $4.10 early in the day so that's a start. I'm trying to keep an open mind for the release, if you're deep into this then it didn't really move the needle much but if you put this in front of new institutional investors its still a compelling story. Patience is key, I know we have all heard that before though...